awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40947815-B8D84143-CE7B-4FD1-9D0B-A144D8FFFA54
Q40947815-B8D84143-CE7B-4FD1-9D0B-A144D8FFFA54
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40947815-B8D84143-CE7B-4FD1-9D0B-A144D8FFFA54
Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
P2860
Q40947815-B8D84143-CE7B-4FD1-9D0B-A144D8FFFA54
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40947815-B8D84143-CE7B-4FD1-9D0B-A144D8FFFA54
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
62a6330ee78f2171fa8aed0c59711359a51e0c94
P2860
Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.